Navigation Links
Surgeons implant second artificial heart

Kentucky surgeons who implanted the world's first self-contained artificial heart in a 59-year-old man more than 2 months ago announced on Thursday that they have installed a second such device in a 70-year-old man. The latest patient, who was not identified, was recovering in intensive care at Jewish Hospital in Louisville, the hospital said in a statement. //

The self-contained mechanical heart, made by Abiomed Inc. of Danvers, Massachusetts, is the first major advance in the development of an artificial replacement heart in nearly two decades. The surgeons have said previously that patients considered for the implant were critically ill with fewer than 30 days to live. The first patient, 59-year-old diabetic Robert Tools, was given the AbioCor plastic and titanium heart device on July 2.

Tools has exceeded initial estimates that the heart would extend his life by about a month and was transferred out of the hospital's intensive care unit earlier this month. The manufacturer of the heart has been given initial regulatory approval for testing of the device on five critically ill patients.


'"/>




Page: 1

Related medicine news :

1. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
2. Surgeons Perform Robotic Gastric Bypass Surgery
3. Surgeons in India to Mend ‘Pakistani Hearts’ by treating 70 Childrn
4. Surgeons Not Happy With Treatment Offered To Their Patients
5. Surgeons being paid triple the amount to cut waiting lists
6. Govt Hospital Surgeons Perform A Rare Cardiac Surgery
7. Virtual Reality Simulation Could Help In Training Surgeons
8. Plastic Surgeons Looking Forward To First Full Face Transplant
9. Cash-Strapped Hospital loses Top Surgeons
10. Surgery Simulators Offer Better Surgeons And Safer Surgeries
11. Surgeons Retrieve ‘Three-Year-Old’ Forceps From Patient’s Abdoen

Post Your Comments:
(Date:11/25/2009)...Minn.,Nov.25/PRNewswire-USNewswire/--Whenmostpeopl...ropractorcanalsogivepatientsthehelptheyneed.TMJsta...jaw(mandible)contacts/connectswithyourskull(tempor...TMJdysfunctionarepainwithchewing,clickingorpopping...functionincluding:headaches,fatigue,sleepdisturban...
(Date:11/25/2009)...ACH,Calif.,Nov.25/PRNewswire/--Thanksgivingmealswi...nthegreaterLongBeachareathankstoFaithInAction/Volu...atHome(IAH),adivisionofSCANHealthPlan.Formorethan1...nteerstodeliverwarmThanksgivingmealstoseniorsinnee...Angelesandsurroundingcities. ,, "Ourwarmholiday...
(Date:11/25/2009)...rvivors of testicular cancer who were treated with... effects, including neurological side effects and ...ted with chemotherapy, according to a new study pu...National Cancer Institute . , Marianne Brydy, M....rsity Hospital, in Bergen, Norway, and colleagues ...
(Date:11/25/2009)...eady used to fight rheumatoid arthritis, could hel... , WEDNESDAY, Nov. 25 (HealthDay News) -- A drug... rheumatoid arthritis now also shows some promise ...abetes. , The drug, rituximab (Rituxan), helped..., even though the disease had destroyed some of th...
(Date:11/25/2009)...K,Nov.25/PRNewswire/-- MISSIONSkincare ®ispro...St.Jude.AspartofGNC,sannualSt.Jude ThanksandGiving...ncare,s new SUPER-C(TM)LipBalm willbedonatedtoSt...omakea$1,$5or$10donationatcheckoutatoneoftheir5,00...an$1millionforSt.Judeduringtheir2009 ThanksandGivi...
Breaking Medicine News(10 mins):Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2
...RG, S.C., Feb. 10 Zeus, Inc. is pleased to introd...live and accessible via http://www.zeusinc.com . ... site is a user-friendly resource for comprehensiv...t of information into four categories listed on th...
..., Ill., Feb. 10 A prestigious panel of pain-manag...ty (APS) www.ampainsoc.org and the American Acad...t comprehensive clinical practice guideline to ass...rent issue of The Journal of Pain , www.jpain.or...
... Cambridge Healthtech Media Group,...ounced the launch of a new website devoted to excl... --www.ecliniqua.com. , N...website devoted to exclusive coverage of the clini...
...ts at the Institute for Myeloma and Bone Cancer Re...ould explain how blood vessels form within tumors....vered a new way that cancers orchestrate the produ...by tumor cells in multiple myeloma, a common form ...
...INGTON, Del., Feb. 10 Four western New York hospi...ing evidence-based therapy and,better communicatio... patient,deaths by 19 percent for up to one year a...Mortality in Patients,with Acute Coronary Syndrome...
...ARD, Calif., Feb. 10 Arete Therapeutics Inc. toda... trial for AR9281, an orally-,administered soluble...d for,the treatment of type 2 diabetes. S-EH is an... "Our AR9281 Phase II clinical trial program break...
Other Medicine News:Health News:New Guidelines for Prescribing Opioid Pain Drugs Published 2Health News:Cambridge Healthtech Media Group Launches Clinical Trials Web Site 2Health News:Cambridge Healthtech Media Group Launches Clinical Trials Web Site 3Health News:Researchers Identify Novel Mechanism That Make Cancer Tumors Grow 2Health News:Emergency Treatment Strategies, Better Communication Among Health Care Workers Reduce Heart Attack Patient Deaths by 19 Percent, Says AHJ Published Study 2Health News:Emergency Treatment Strategies, Better Communication Among Health Care Workers Reduce Heart Attack Patient Deaths by 19 Percent, Says AHJ Published Study 3Health News:Emergency Treatment Strategies, Better Communication Among Health Care Workers Reduce Heart Attack Patient Deaths by 19 Percent, Says AHJ Published Study 4Health News:Arete Therapeutics Initiates Phase IIa Clinical Trial for AR9281, a Novel s-EH Inhibitor to Treat Type 2 Diabetes 2Health News:Arete Therapeutics Initiates Phase IIa Clinical Trial for AR9281, a Novel s-EH Inhibitor to Treat Type 2 Diabetes 3
(Date:11/24/2009)...ov.24/PRNewswire/-- EisaiInc.andPfizerIncannounce...acceptedforreviewEisai,sNewDrugApplication(NDA)for...ease)tabletsforthetreatmentofmoderatetosevereAlzhe...ains23mgofdonepezilHClinanextendedrelease,matrix-t...leaseofthedrug.TheNDAisbasedonahead-to-headclinica...
(Date:11/24/2009)...swire-FirstCall/--ThoratecCorporation(Nasdaq: THOR...supporttherapiestosave,supportandrestorefailinghea...ualPiperJaffrayHealthCareConferenceonTuesday,Decem...chieffinancialofficer,willprovideanupdateonthecomp...m.,PacificStandardTime). ,, Thepresentationwill...
(Date:11/24/2009)...re/--ZargisMedicalCorp.,asubsidiaryofSpeedusCorp.(...arch(NYSE: SI ),todayannouncedthatitsZargisCardios...BS, TheEarlyShow duringasegmentinwhichMarkJannot,t...ningproductsfromthepublication,s2009"BestofWhat,sN...evisionmorningnewstalkshowbroadcastbyCBSfromNewYor...
Breaking Medicine Technology:FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Zargis Cardioscan(TM) Featured on The Early Show on CBS 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 3MedAssurant to Support AHIPs Research Capabilities 57024 1MedAssurant to Support AHIPs Research Capabilities 57024 2Thoratec Presentation at UBS Conference to be Webcast 57022 1Enobia Announces Positive Clinical Results With ENB 0040 a Bone Targeted Enzyme Replacement Therapy for Hypophosphatasia 4996 1Enobia Announces Positive Clinical Results With ENB 0040 a Bone Targeted Enzyme Replacement Therapy for Hypophosphatasia 4996 2Enobia Announces Positive Clinical Results With ENB 0040 a Bone Targeted Enzyme Replacement Therapy for Hypophosphatasia 4996 3
...INGSTON, N.J.--(BUSINESS WIRE)--Jun 25, 2007 - Col...today that an interim,analysis of a pregnancy stud...erone gel) to compounded intramuscular progesteron...l be published in,Fertility and Sterility, the jou...cine (ASRM)., This ongoing prospective randomized ...
...YMOUTH MEETING, Pa., June 25, 2007 /PRNewswire-Fir...t data from a preclinical,study of trodusquemine (...ted during the American Diabetes Association (ADA)...IL. Dr. Kristen Lantz,Genaera research scientist ...rodusquemine is a Multiple Pathway Inhibitor that,...
Other Medicine Technology:Interim Analysis of Crinone Pregnancy Study to Be Published in,American Society for Reproductive Medicine Journal 2Interim Analysis of Crinone Pregnancy Study to Be Published in,American Society for Reproductive Medicine Journal 3Interim Analysis of Crinone Pregnancy Study to Be Published in,American Society for Reproductive Medicine Journal 4Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for,the Treatment of Obesity at the American Diabetes Association 67th,Scientific Session 2Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for,the Treatment of Obesity at the American Diabetes Association 67th,Scientific Session 3Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for,the Treatment of Obesity at the American Diabetes Association 67th,Scientific Session 4
RGP OrthoK Lenses
... rigid gas permeable contact lenses used for corne...corrects nearsightedness (myopia). The patient wea... them upon wakening. During the day, nearsightedne...RT and Quadra RG contact lenses apply slight press...
...ware of the High Prevalence of Sleep Disordered Br...t Population?, , As Prevalent as Diabetes, with Va...OSA), the most common form of SDB, affects an esti...y 5% of the OSA patients have been diagnosed, leav...
... SP-9000 is exactly the same as the model SP-8800 ...separate Pachy mode. This mode has its own fixatio...directions. It allows you to select an area on the...t-in software to calculate averages of multiple re...
Medicine Products: